CYTRX &lt;CYTR> UNIT BUYS SWEDISH COMPANY

  CytRx Corp said its 60 pct owned CytRx
  Biopool Ltd subsidiary has acquired Biopool AB of Umea, Sweden,
  for undisclosed terms.
      It said former shareholders of Biopool AB own the remaining
  40 pct in CytRx Biopool Ltd. Biopool AB develops cardiovascular
  and fibrinolytic products for diagnostic applications.
      The company said CytRx Biopool is studying the possible
  combination of CytRx Corp's RheothRx drug to reduce platelet
  aggregation and viscosity in blood with Biopool AB's drug t-PA
  for dissolving blood clots.
  

